Loading stock data…
$6.53-0.53 (-7.51%)
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
Maravai LifeSciences Holdings, Inc. in the Healthcare sector is trading at $6.53 with a market capitalization of $2.7B. Wall Street consensus targets $7.83 (6 analysts), implying a +20.0% move over the next 12 months. The stock is currently 31% below its 52-week high of $9.42, remaining 30.9% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $51.44M↓ | $65.84M↑ | $49.87M↑ | $41.63M↓ | $47.40M |
| Gross Profit | $20.65M↓ | $33.70M↑ | $12.84M↑ | $5.66M↓ | $7.77M |
| Operating Income | -$15.12M↓ | $720,000↑ | -$22.53M↑ | -$33.59M↑ | -$35.83M |
| Net Income | -$12.42M↓ | -$3.73M↑ | -$35.68M↓ | -$25.56M↑ | -$39.59M |
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia...